AtaiBeckley Inc.
VLS-01
treatment-resistant depression
Countdown
177days
Phase 2 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 2 trial results for VLS-01 in treatment-resistant depression are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“Elumina Phase 2 topline results anticipated in Q4 2026.”